Abiopharma

🔍 Mayer Bethany (Director)

Company: Hewlett Packard Enterprise Co (HPE)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 6,482 shares of Common Stock at $29.1 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,018.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: by JM2002Trust | shares_owned_after: 20,078.00
• Acquired 8,750 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,750.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
• F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.
• REMARKS: The reported sale occurred pursuant to a trading plan adopted on 12/17/25.